CA Patent

CA2550726A1 — Methods of preparing aripiprazole crystalline forms

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2005-06-30 · 21y expired

What this patent protects

The invention encompasses aripiprazole crystalline forms, methods of preparing the same, and pharmaceutical compositions having aripiprazole crystalline forms.

USPTO Abstract

The invention encompasses aripiprazole crystalline forms, methods of preparing the same, and pharmaceutical compositions having aripiprazole crystalline forms.

Drugs covered by this patent

Patent Metadata

Patent number
CA2550726A1
Jurisdiction
CA
Classification
—
Expires
2005-06-30
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.